Acurx Reports Q1 2026 Earnings and Financial Update
Acurx (ACXP) reported its first-quarter earnings for 2026, showing a net loss of $1.7 million or $0.62 per diluted share compared to the previous quarter's loss of $2.15 per share. The company raised approximately $3.1 million through equity financing and reduced both R&D and general administrative expenses.
Tickers: $ACXP
Topics: clinical_trials financials